New research has uncovered a hidden pathway that allows COVID-19 to infect the immune system and trigger damaging ...

In case you missed it, Kate Middleton recently completed the National Three Peaks Challenge, an ambitious trek that involves ...

LA28 Cricket Qualification Explained: Cricket’s return to the Olympic Games after a gap of 128 years took a significant step forward on Monday after the International Olympic Committee (IOC) approved ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A hard-line GOP lawmaker has introduced legislation that would ...

Be careful what you wish for. This idea, often explored in fiction, lies at the center of “Obsession,” Focus Features‘ new horror film from writer/director/editor Curry Barker. The movie follows Bear ...

The Philadelphia Eagles roster the most successful player to emerge from the International Player Pathway program: left tackle Jordan Mailata. Following the seventh round of the 2026 NFL Draft, their ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Lizzy leads STAT’s coverage of the FDA. Her ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

Rhythm Biosciences Ltd. launched a new genetype colorectal cancer risk assessment clinical test that incorporates clinical and lifestyle risk factors alongside its established 140-SNP polygenic risk ...